Trials (Aug 2022)

Integrated traditional Chinese medicine intervention for delaying HIV morbidity: study protocol for a multicentre randomised controlled trial

  • Xue Ding,
  • Pengfei Meng,
  • Xiuxia Ma,
  • Weifeng Cui,
  • Liangping Li,
  • Xiyuan Song,
  • Jiangrong Wang,
  • Chengjie Ma,
  • Xin Chen,
  • Liran Xu

Journal volume & issue
Vol. 23, no. 1
pp. 1 – 8


Read online

Abstract Background Acquired immune deficiency syndrome is caused by humans and is high worldwide. Active antiretroviral therapy emerged in the late 1990s and is effective against AIDS. However, despite the extensive research on AIDS, there is still no vaccine or cure. The benefits of traditional Chinese medicine (TCM) for AIDS are increasingly recognised, especially by patients with asymptomatic HIV infection. Methods/design The proposed trial will enrol 216 eligible patients who will be randomised into treatment and control groups. After 72 weeks of intervention, the efficacy and safety of TCM for patients with AIDS will be assessed. The variables that will be measured include clinical symptoms, TCM syndromes, viral load, immunological indicators, inflammatory factors, quality of life, patient-reported outcomes and safety assessment. Discussion The study aim to compare the effectiveness and safety of TCM for asymptomatic AIDS and explore its potential underlying mechanism. Additionally, the findings will provide a reference for the use of TCM to delay the onset and control the progression of HIV/AIDS. Trial registration Chinese Clinical Trial Registry ChiCTR1800018365. Registered on 13 September 2018